Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $220000.0.

  • Lucid Diagnostics' Depreciation & Amortization (CF) rose 232.56% to $220000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $885000.0, marking a year-over-year decrease of 4377.38%. This contributed to the annual value of $1.2 million for FY2024, which is 5330.13% down from last year.
  • As of Q3 2025, Lucid Diagnostics' Depreciation & Amortization (CF) stood at $220000.0, which was up 232.56% from $222000.0 recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Depreciation & Amortization (CF) registered a high of $704000.0 during Q2 2022, and its lowest value of $24000.0 during Q1 2022.
  • Moreover, its 4-year median value for Depreciation & Amortization (CF) was $501000.0 (2024), whereas its average is $417666.7.
  • In the last 5 years, Lucid Diagnostics' Depreciation & Amortization (CF) surged by 245000.0% in 2023 and then plummeted by 6560.0% in 2024.
  • Lucid Diagnostics' Depreciation & Amortization (CF) (Quarter) stood at $615000.0 in 2022, then rose by 2.28% to $629000.0 in 2023, then plummeted by 64.71% to $222000.0 in 2024, then fell by 0.9% to $220000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $220000.0 for Q3 2025, versus $222000.0 for Q2 2025 and $221000.0 for Q1 2025.